Today is

Department of

Center for Integrative Health and Wellness

Photo of  Jill Boone, Pharm.D.

Jill Boone, Pharm.D.

Director of Interprofessional Education<br>Interim Co-Curricular Director<br>Clinical Professor

Contact Information

Peer Reviewed Publications

Display All

Gorevski, E; Succop, P; Sachdeva, J; Scott, R; Benjey, J; Varughese, G; Martin-Boone, J 2011. Factors influencing posttransplantation employment: does depression have an impact? Transplantation proceedings, 43 10, 3835-9

Gorevski, E; Wead, S; Tevar, A; Succop, P; Volek, P; Martin-Boone, J 2011. Retrospective evaluation of donor pain and pain management after laprascopic nephrectomy. Transplantation proceedings, 43 7, 2487-91

Cavanaugh, Teresa M; Parrish, Nicholas; Neff, Guy; Rudich, Steven; Martin-Boone, Jill 2010. The impact of a change in tacrolimus monitoring immunoassay techniques on clinical decision making. Progress in transplantation (Aliso Viejo, Calif.), 20 4, 350-6

Read, Douglas H; Martin, James E 2010. Strain-tunable chemiresistor. Analytical chemistry, 82 5, 2150-4

Kotsos, Thomas; Muldowney, Kevin; Chapa, Griselda; Martin, J Eric; Linares, Antonio 2009. Challenges and solutions in the evaluation of a low back pain disease management program. Population health management, 12 1, 39-45

Cavanaugh, Teresa M; Martin, Jill E 2007. Update on pharmacoeconomics in transplantation. Progress in transplantation (Aliso Viejo, Calif.), 17 2, 103-19; quiz 120

Buell, Joseph F; Lee, Lucy; Martin, Jill E; Dake, Natalie A; Cavanaugh, Teresa M; Hanaway, Michael J; Weiskittel, Pat; Munda, Rino; Alexander, J Wesley; Cardi, Michael; Peddi, V Ram; Zavala, Edward Y; Berilla, Elaine; Clippard, Marketa; First, M Roy; Woodle, E Steve 2005. Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study. Clinical transplantation, 19 1, 102-9

Martin, Jill E 2005. From coal to diamond: transforming health-system pharmacy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 62 16, 1693-6

Martin, Jill E; Zavala, Edward Y 2004. The expanding role of the transplant pharmacist in the multidisciplinary practice of transplantation. Clinical transplantation, 18 Suppl 12 , 50-4

Whiting, J F; Woodward, R S; Zavala, E Y; Cohen, D S; Martin, J E; Singer, G G; Lowell, J A; First, M R; Brennan, D C; Schnitzler, M A 2000. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation, 70 5, 755-60

Martin, J E; Daoud, A J; Schroeder, T J; First, M R 1999. The clinical and economic potential of cyclosporin drug interactions. PharmacoEconomics, 15 4, 317-37

Shah, M B; Martin, J E; Schroeder, T J; First, M R 1999. The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis. Transplantation, 67 11, 1411-7

Baker, G M; Martin, J E; Jang, R; Schroeder, T J; Armitstead, J A; Myre, S; First, M R 1998. Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation. Transplantation proceedings, 30 8, 4082-4

Martin, J E; Fleck, P; Schroeder, T J; Whiting, J F; Hanto, D W 1998. The cost of rejection in liver allograft recipients. Transplantation proceedings, 30 4, 1500-1

Shah, M B; Martin, J E; Schroeder, T J; First, M R 1998. A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral. Transplantation proceedings, 30 8, 4048-53

Shah, M B; Martin, J E; Schroeder, T J; First, M R 1998. Evaluation of the safety and tolerability of Neoral and Sandimmune: a meta-analysis. Transplantation proceedings, 30 5, 1697-700

Lutomski, D M; Gora, M L; Wright, S M; Martin, J E 1993. Sorbitol content of selected oral liquids. The Annals of pharmacotherapy, 27 3, 269-74

Martin, Jill E; Cavanaugh, Teresa M; Trumbull, Leslie; Bass, Maryetta; Weber, Fredrick Jr; Aranda-Michel, Jaime; Hanaway, Michael; Rudich, Steven 01-2008. Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients. Clinical Transplantation, 22 1, 113

Boyd, S R; Martin, J E; First, M R; Whiting, J F . Health utility scores following renal transplantation. Transplantation proceedings, 33 1-2, 1900

Khosla, U M; Martin, J E; Baker, G M; Schroeder, T J; First, M R . One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation. Transplantation proceedings, 31 1-2, 274-5

Martin, J E; Lutomski, D M . Warfarin resistance and enteral feedings. JPEN. Journal of parenteral and enteral nutrition, 13 2, 206-8

Martin, J E; Shireman, T I; First, M R; Whiting, J F . Quality of life following solid organ transplantation in Medicaid beneficiaries. Transplantation proceedings, 33 1-2, 1909

Martin, Jill E; Cavanaugh, Teresa M; Trumbull, Leslie; Bass, Maryetta; Weber, Fredrick; Aranda-Michel, Jaime; Hanaway, Michael; Rudich, Steven . Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients. Clinical transplantation, 22 1, 113-9

Phillips, A L; Walker, E L; Martin, J E; First, M R; Hanto, D W; Whiting, J F . Quality of life as a predictor of morbidity, mortality, and resource utilization after solid organ transplant. Transplantation proceedings, 33 1-2, 1922

Shah, M B; Martin, J E; Schroeder, T J; First, M R . Validity of open labeled versus blinded trials: a meta-analysis comparing Neoral and Sandimmune. Transplantation proceedings, 31 1-2, 217-9

Shireman, T I; Martin, J E; Whiting, J F . The cost of transplant graft maintenance following solid organ transplantation. Transplantation proceedings, 33 1-2, 1920-1

Whiting, J F; Martin, J E; Cohen, D; Woodward, R; Singer, G; Lowell, J; Howard, T; Woodle, E S; Brennan, D; Schnitzler, M A . Economic outcome of simultaneous pancreas kidney transplantation compared with kidney transplantation alone. Transplantation proceedings, 33 1-2, 1923